Current Surgical, a US-based medical equipment manufacturing start-up, has raised $3.2 million in seed funding from investors including 1517 Fund, True Ventures, and SciFounders. The company is focused on developing a new class of microinvasive therapies, with a goal of treating cancer at any stage and in any location.

Current Surgical's technology is designed to enable minimally invasive surgery using small, flexible robotic tools that can be easily maneuvered by physicians. The company aims to make surgeries safer, more accessible, and less traumatic for patients.

The seed funding will allow Current Surgical to continue its research and development efforts, as well as expand its team and bring its technology to market. The company is led by a team of experienced entrepreneurs, scientists, and engineers with backgrounds in robotics, medical devices, and healthcare.

With the support of its investors, Current Surgical is well-positioned to make significant advancements in the field of microinvasive therapies and improve outcomes for cancer patients around the world. Click the link to find more information about Current Surgical's recent funding round: https://founderlodge.com/round/Current-Surgical-raises-3200000-Seed-2023-02-24-Al-Mashal-OTg2Ng